Orion Pharma declares 10% cash dividend

The Board of Directors of Orion Pharma has recommended a 10 percent cash dividend for the 2019-20 fiscal year. 

An annual general meeting of the company is scheduled to take place on December 23. 

The company also reported consolidated earnings per sharing (EPS) of Tk 2.84 and consolidated net asset value (NAV) per share (Including Revaluation Surplus) of Tk 76.77 for 2019-20 FY, against Tk 3.77 and Tk 75.19 respectively for the same period of last fiscal year. 

It also declared the consolidated net operating cash flow per share (NOCFPS) of Tk 8.04 against Tk 6.19.

Following the corporate declaration, there will be no price limit on the trading of the shares of the company. However, the floor price set by the Bangladesh Securities Exchange Commission (BSEC) will be applicable accordingly.